Nanostics Announces Publication of a ClarityDX Prostate Study Validating New Algorithms with Improved Cancer Prediction that make MRI or DRE Optional

EDMONTON, AB, April 20, 2026 /PRNewswire/ - Nanostics Inc., a precision health company advancing diagnostic innovation through its ClarityDX (R) platform, today announced the publication of a ...

(CNW) Nanostics Announces Publication of a ClarityDX Prostate Study Validating New Algorithms with Improved Cancer Prediction that make MRI or DRE Optional

EDMONTON, AB, April 20, 2026 /CNW/ - Nanostics Inc., a precision health company advancing diagnostic innovation through its ClarityDX (R) platform, today announced the publication of a peer-reviewed ...
HealthDay on MSN

SIR: Minimally invasive prostate cancer treatment shows faster recovery than robotic prostatectomy

Magnetic resonance imaging (MRI)-guided transurethral ultrasound ablation (TULSA) shows better initial perioperative outcomes ...

SMALL CAP IDEA: These five firms could benefit from the scramble for secure alternatives to helium

The gas keeping the world's MRI scanners running and AI chips cool is suddenly in critically short supply. Five AIM-listed ...